News Daily News Radial Superior to Femoral Access in Patients With Prior CABG Michael O'Riordan April 07, 2021
News Daily News Mobile Tech May Boost CAD Secondary Prevention for Older Adults L.A. McKeown April 07, 2021
News Daily News Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients Shelley Wood April 06, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021
News Daily News Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All L.A. McKeown April 05, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Daily News ‘Gaming’ the AUC for Revascularization? Study Suggests Not Michael O'Riordan March 25, 2021
News Daily News Watch Out for Differences Among High-Sensitivity Troponin Assays Todd Neale March 24, 2021
News Daily News Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk Michael O'Riordan March 23, 2021
News Features Crude Awakening: Should Interventional Cardiology Come Clean on Dirty Talk? Shelley Wood March 22, 2021
News Daily News Experts Fear Coronary CT Advice for Patients Misses the Mark Michael O'Riordan March 19, 2021
News Daily News AHA Highlights Unique Needs of Opioid-Associated Cardiac Arrest Shelley Wood March 18, 2021
News Daily News Invasive Approach Best for Cocaine-Linked NSTEMI, but DAPT Is Key Michael O'Riordan March 16, 2021
News Daily News Biggest Benefits of Regular Fish Consumption Lie in Secondary Prevention Michael O'Riordan March 11, 2021
News Conference News CRT 2021 Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows Michael O'Riordan March 09, 2021
News Daily News Low Incidence of Myocarditis Among Pro Athletes Diagnosed With COVID-19 Michael O'Riordan March 05, 2021
News Daily News MI Hospitalizations Down 20% at COVID-19 Peak in Italy, With a Heavy Cost Michael O'Riordan March 04, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021